AlzeCure Pharma
Develops small-molecule drug therapies for Alzheimer's, pain, and cognitive dysfunction.
ALZCUR | ST
Overview
Corporate Details
- ISIN(s):
- SE0010133785 (+1 more)
- LEI:
- 5493001EJLEBXFY6I446
- Country:
- Sweden
- Address:
- Hälsovägen 7, 141 57 Huddinge
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
AlzeCure Pharma is a pharmaceutical company specializing in the research and development of innovative small-molecule drug therapies for severe diseases. The company's primary focus is on Alzheimer's disease, developing a broad portfolio of symptomatic, disease-modifying, and preventive treatments. Its research also extends to other areas, including pain and conditions involving cognitive dysfunction. AlzeCure's business model is centered on advancing drug candidates through preclinical and early-stage clinical development. A key candidate in its pipeline is NeuroRestore ACD856, a potential Alzheimer's treatment that has entered Phase 2 clinical trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AlzeCure Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AlzeCure Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AlzeCure Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
